Alfa glucosidase inhibitory, anti inflammatory activities and a new furanocoumarin derivative of Ruellia tuberosa

Nat Prod Res. 2021 Nov;35(22):4248-4255. doi: 10.1080/14786419.2019.1696790. Epub 2019 Nov 29.

Abstract

Rullia tuberosa L. is used for treatment of diabetes mellitus, anti-inflammation, etc. However, its hypoglycaemic and anti inflammatory activities has not been investigated so far. In the present study, the α-glucosidase inhibitory, anti inflammatory activities of the extract of this plant were investigated. Our results showed that the crude extract as well as ethyl acetate and methanol fractions showed α-glucosidase inhibitory activity with IC50 of 15.84, 4.73 and 8.27 µg/ml, respectively. In addition, the hexane and ethyl acetate fractions are capable of inhibiting LPS-induced NO production with IC50 of 17.41 and 23.95 µg/mL, respectively. From the ethyl acetate and methanol fractions, eight compounds, including isobargaptol 5-O-β-D-glucopyranoside (1), syringaresinol (2), catechin (3), pulmatin (4), stigmast-4-en-3-on (4), verbascoside (5), hydroxymethylfurfural (6), rutin (7), and homoplantaginin (8) were extracted and isolated. Their chemical structures were elucidated by spectroscopic method including MS, 1 D and 2 D- NMR and comparison with the literature values.

Keywords: Furanocoumarin; Ruellia tuberosa; anti inflammation; α-glucosidase inhibition.

MeSH terms

  • Acanthaceae*
  • Anti-Inflammatory Agents / pharmacology
  • Furocoumarins*
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Plant Extracts / pharmacology
  • alpha-Glucosidases

Substances

  • Anti-Inflammatory Agents
  • Furocoumarins
  • Glycoside Hydrolase Inhibitors
  • Plant Extracts
  • alpha-Glucosidases